Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Unilife Corp (NASDAQ:UNIS)

1.41
Delayed Data
As of Sep 03
 +0.02 / +1.44%
Today’s Change
1.12
Today|||52-Week Range
4.90
-57.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$183.5M

Company Description

Unilife Corp. designs, develops, manufactures and supplies injectable drug delivery systems. The company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its innovative and differentiated devices to enable or enhance the clinical development, regulatory approval and lifecycle management of their injectable therapies. Its lead product is the Unifill ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with their injectable drugs and vaccines. Unilife was founded by Alan D. Shortall in 2001 and is headquartered in York, PA.

Contact Information

Unilife Corp.
250 Cross Farm Lane
York Pennsylvania 17406
P:(717) 384-3400
Investor Relations:
(128) 346-6500

Employees

Shareholders

Mutual fund holders20.98%
Other institutional18.88%
Individual stakeholders12.31%

Top Executives

Alan D. ShortallChairman & Chief Executive Officer
Ramin MojdehbakhshPresident, Chief Operating Officer & Executive VP
David C. HastingsChief Financial Officer & Senior Vice President
Richard L. BeckmanChief Medical Officer & Senior Vice President
Mark V. IampietroVP-Corporate Quality & Regulatory Affairs